• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Update: Annual Changes to the Nasdaq-100® Index

    12/12/23 6:00:00 PM ET
    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Investment Bankers/Brokers/Service
    Finance
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $NDAQ alert in real time by email

    NEW YORK, Dec. 12, 2023 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced an update to the annual reconstitution of the Nasdaq-100 Index® (NASDAQ:NDX). Per the announcement by Pfizer Inc. (NYSE:PFE), the pending acquisition of Seagen, Inc. (NASDAQ:SGEN) is expected to close on December 14, 2023. As a result, Take-Two Interactive Software, Inc. (NASDAQ:TTWO), will be added to the Nasdaq-100 Index® and Seagen, Inc. will be removed as part of the annual reconstitution, which will become effective prior to market open on Monday, December 18, 2023.

    The other constituent changes from the initial announcement by Nasdaq on Friday, December 8, 2023, will remain the same.

    Information

    For information about the company being added to the Nasdaq-100 Index® per this update, please visit the company website: Take-Two Interactive Software, Inc. – https://www.take2games.com/.

    About Nasdaq Global Indexes

    Nasdaq Global Indexes has been creating innovative, market-leading, transparent indexes since 1971. Today, our index offering spans geographies and asset classes and includes diverse families such as the Dividend and Income (includes Dividend Achievers), Nasdaq Dorsey Wright, Fixed Income (includes BulletShares®), Global Equity, Green Economy, Nordic, and Commodity indexes. We continuously offer new opportunities for financial product sponsors across a wide spectrum of investable products and for asset managers to measure risk and performance. Nasdaq also provides exchange listing, custom index, and design solutions to financial organizations worldwide.

    About Nasdaq

    Nasdaq (NASDAQ:NDAQ) is a leading global technology company serving corporate clients, investment managers, banks, brokers, and exchange operators as they navigate and interact with the global capital markets and the broader financial system. We aspire to deliver world-leading platforms that improve the liquidity, transparency, and integrity of the global economy. Our diverse offering of data, analytics, software, exchange capabilities, and client-centric services enables clients to optimize and execute their business vision with confidence. To learn more about the company, technology solutions, and career opportunities, visit us on LinkedIn, on X @Nasdaq, or at www.nasdaq.com.

    The information contained above is provided for informational and educational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular financial product or an overall investment strategy. Neither The Nasdaq OMX Group, Inc. nor any of its affiliates makes any recommendation to buy or sell any financial product or any representation about the financial condition of any company or fund. Statements regarding Nasdaq's proprietary indexes are not guarantees of future performance. Actual results may differ materially from those expressed or implied. Past performance is not indicative of future results. Investors should undertake their own due diligence and carefully evaluate companies before investing. ADVICE FROM A SECURITIES PROFESSIONAL IS STRONGLY ADVISED.

    - NDAQG -

    Media Relations ContactsInvestor Relations Contact  
    Name: Camille StaffordName: Index Client Services  
    Email: Camille.Stafford@nasdaq.com

    Email  indexservices@nasdaq.com  
      
    Name: Jennifer Lawson 
    Email: Jennifer.Lawson@nasdaq.com 
      


    Primary Logo

    Get the next $NDAQ alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NDAQ
    $PFE
    $SGEN
    $TTWO

    CompanyDatePrice TargetRatingAnalyst
    Take-Two Interactive Software Inc.
    $TTWO
    6/2/2026$280.00Overweight
    Piper Sandler
    Nasdaq Inc.
    $NDAQ
    4/8/2026$92.00Mkt Perform
    Keefe Bruyette
    Pfizer Inc.
    $PFE
    3/2/2026$35.00Hold → Buy
    Argus
    Nasdaq Inc.
    $NDAQ
    2/26/2026$106.00Hold → Buy
    TD Cowen
    Pfizer Inc.
    $PFE
    2/25/2026$25.00Underperform
    RBC Capital Mkts
    Pfizer Inc.
    $PFE
    2/20/2026$25.00Underweight
    Barclays
    Pfizer Inc.
    $PFE
    2/12/2026$27.00Outperform → Neutral
    Daiwa Securities
    Take-Two Interactive Software Inc.
    $TTWO
    2/10/2026$285.00Outperform → Strong Buy
    Raymond James
    More analyst ratings

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President Slatoff Karl returned 64,812 shares to the company, sold $56,228,879 worth of shares (249,327 units at $225.52) as part of a pre-agreed trading plan, disposed of 209,805 shares as part of a pre-agreed trading plan, acquired 40,358 shares as part of a pre-agreed trading plan and was granted 329,949 shares (SEC Form 4) (withholding obligation)

    4 - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Issuer)

    6/3/26 6:30:22 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Chairman, CEO Zelnick Strauss disposed of 209,805 shares as part of a pre-agreed trading plan, gifted 85,850 shares, received a gift of 85,850 shares, was granted 329,949 shares, returned 64,812 shares to the company and sold $47,507,973 worth of shares (208,969 units at $227.34) as part of a pre-agreed trading plan, closing all direct ownership in the company (SEC Form 4) (for tax liability)

    4 - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Issuer)

    6/3/26 6:26:09 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Chief Financial Officer Goldstein Lainie returned 14,001 shares to the company, was granted 57,135 shares and sold $6,821,087 worth of shares (31,060 units at $219.61) as part of a pre-agreed trading plan, increasing direct ownership by 4% to 283,374 units (SEC Form 4) to cover taxes

    4 - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Issuer)

    6/3/26 6:03:24 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    October 25, 2024 - FDA Roundup: October 25, 2024

    For Immediate Release: October 25, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA updated the advisory for the outbreak of E. coli O157:H7. A specific ingredient has not yet been confirmed as the source of the outbreak, but most sick people report eating McDonald’s Quarter Pounder burgers. Investigators are working to deter

    10/25/24 2:48:21 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for HYMPAVZI issued to PFIZER INC

    Submission status for PFIZER INC's drug HYMPAVZI (ORIG-1) with active ingredient MARSTACIMAB-HNCQ has changed to 'Approval' on 10/11/2024. Application Category: BLA, Application Number: 761369, Application Classification:

    10/15/24 2:57:27 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    October 11, 2024 - FDA Approves New Treatment for Hemophilia A or B

    For Immediate Release: October 11, 2024 Today, the U.S. Food and Drug Administration approved Hympavzi (marstacimab-hncq) for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adult and pediatric patients 12 years of age and older with hemophilia A without factor VIII inhibitors or hemophilia B without factor IX inhibitors (neutralizing antibodies). “Today’s approval of Hympavzi pro

    10/11/24 2:12:15 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Torgeby Johan bought $958,320 worth of shares (12,000 units at $79.86), increasing direct ownership by 42% to 40,797 units (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/19/26 4:00:18 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Large owner Investor Ab bought $15,835,040 worth of shares (200,000 units at $79.18) (SEC Form 4)

    4 - NASDAQ, INC. (0001120193) (Issuer)

    2/13/26 3:56:39 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Director Blaylock Ronald E bought $499,072 worth of shares (19,457 units at $25.65), increasing direct ownership by 236% to 27,707 units (SEC Form 4)

    4 - PFIZER INC (0000078003) (Issuer)

    2/14/25 5:16:36 PM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    SEC Filings

    View All

    SEC Form S-3ASR filed by Take-Two Interactive Software Inc.

    S-3ASR - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Filer)

    6/1/26 4:11:50 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    SEC Form DEFA14A filed by Nasdaq Inc.

    DEFA14A - NASDAQ, INC. (0001120193) (Filer)

    5/27/26 4:05:28 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Take-Two Interactive Software Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - TAKE TWO INTERACTIVE SOFTWARE INC (0000946581) (Filer)

    5/21/26 4:08:54 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Piper Sandler initiated coverage on Take-Two with a new price target

    Piper Sandler initiated coverage of Take-Two with a rating of Overweight and set a new price target of $280.00

    6/2/26 8:38:27 AM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    Keefe Bruyette resumed coverage on NASDAQ with a new price target

    Keefe Bruyette resumed coverage of NASDAQ with a rating of Mkt Perform and set a new price target of $92.00

    4/8/26 8:37:55 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Pfizer upgraded by Argus with a new price target

    Argus upgraded Pfizer from Hold to Buy and set a new price target of $35.00

    3/2/26 8:00:47 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Nasdaq Reports May 2026 Volumes

    NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today reported monthly volumes for May 2026 on its Investor Relations website. A data sheet showing this information can be found at: https://ir.nasdaq.com/financials/volume-statistics.  About NasdaqNasdaq (NASDAQ:NDAQ) is a leading technology platform that powers the world's economies. We architect the infrastructure of the world's most modern markets, power the innovation economy, and build trust in the financial system. We empower economic opportunity by designing and deploying advanced technology, data, and intelligence solutions that enable our clients to capture opportunities, navigate risk, and strengthen resilience.

    6/3/26 4:05:00 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Nasdaq Resumes Trading in TJGC Group Limited

    NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- The Nasdaq Stock Market® (NASDAQ:NDAQ) announced that trading will resume in TJGC Group Limited (NASDAQ:TJGC) at 12:00 p.m. Eastern Time on June 3, 2026. Trading in the company's ordinary shares was halted on May 15, 2026 at 18:50:47 Eastern Time. For news and additional information about the company, please contact the company directly or check under the company's symbol using InfoQuotesSM on the Nasdaq® Web site. For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com. Nasdaq Contact: Nasdaq MarketWatchdl-NasdaqMarketWatch@nasdaq.com NDAQO

    6/3/26 11:30:00 AM ET
    $NDAQ
    $TJGC
    Investment Bankers/Brokers/Service
    Finance
    Advertising
    Consumer Discretionary

    Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

    Pfizer Inc. (NYSE:PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 8:00 a.m. EDT. To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days. About Pfizer: Bre

    6/1/26 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Leadership Updates

    Live Leadership Updates

    View All

    Lumentum Holdings Inc. to Join the Nasdaq-100 Index® Beginning May 18, 2026

    NEW YORK, May 08, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Lumentum Holdings Inc. (NASDAQ:LITE) will become a component of the Nasdaq-100 Index® replacing CoStar Group, Inc. (NASDAQ:CSGP) prior to market open on Monday, May 18, 2026. For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/ About Nasdaq Global Indexes Nasdaq Global Indexes is one of the world's leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Index® — which measures the performance of 100 of the largest Nasdaq-listed non-financial companies — is tracked by more than 2

    5/8/26 8:00:00 PM ET
    $CSGP
    $LITE
    $NDAQ
    Real Estate
    Telecommunications Equipment
    Telecommunications
    Investment Bankers/Brokers/Service

    Sandisk Corporation to Join the Nasdaq-100 Index® Beginning April 20, 2026

    NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) -- Nasdaq (NASDAQ:NDAQ) today announced that Sandisk Corporation (NASDAQ:SNDK) will become a component of the Nasdaq-100 Index® (NDX®) replacing Atlassian Corporation (NASDAQ:TEAM) prior to market open on Monday, April 20, 2026. These updates are consistent with the current Nasdaq-100 Index® methodology, in effect through April 30, 2026. For additional information, including notifications on changes to any Nasdaq Indexes, please go to https://indexes.nasdaq.com/ About Nasdaq Global Indexes Nasdaq Global Indexes is one of the world's leading index providers, offering a comprehensive suite of rules-based benchmarks and indexes. The Nasdaq-100 Inde

    4/10/26 8:00:00 PM ET
    $NDAQ
    $SNDK
    $TEAM
    Investment Bankers/Brokers/Service
    Finance
    Electronic Components
    Technology

    The Show Never Stops in WWE® 2K26 King of Kings Edition, Attitude Era Edition, and Monday Night War Edition Available Now Worldwide

    Franchise evolution marked by improvements and additions to every game mode, four new match types, biggest roster ever, interactive environments, updated storylines, expanded customization features, and more Today, 2K announced King of Kings Edition, Attitude Era Edition, and Monday Night War Edition of WWE® 2K26, the newest installment of the flagship WWE video game franchise developed by Visual Concepts, are available now for PlayStation®5 (PS5®), Xbox Series X|S, Nintendo Switch™ 2, and PC via Steam. The Standard Edition, featuring cover star and current WWE World Heavyweight Champion, CM Punk, will be available on Friday, March 13, 2026. This press release features multimedia. View t

    3/6/26 8:00:00 AM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Financials

    Live finance-specific insights

    View All

    Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference

    Pfizer Inc. (NYSE:PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 8:00 a.m. EDT. To listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days. About Pfizer: Bre

    6/1/26 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

    Pfizer Inc. (NYSE:PFE) invites investors and the general public to view and listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Jefferies Global Healthcare Conference in New York on Wednesday, June 3, 2026 at 2:00 p.m. EDT. To view and listen to the webcast, visit our web site at www.pfizer.com/investors. Information on accessing and registering for the webcast will be available at www.pfizer.com/investors beginning today. The transcript and webcast replay of the discussion will be made available on our web site at www.pfizer.com/investors within 24 hours after the end of the live discussion and will be accessible for at least 90 days.

    5/27/26 10:00:00 AM ET
    $PFE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Take-Two Interactive Software, Inc. Reports Results for Fourth Quarter and Fiscal Year 2026

    $1.58 billion fiscal fourth quarter Net Bookings, above Company's guidance range $6.72 billion fiscal year 2026 Net Bookings Initial outlook for fiscal 2027 includes Net Bookings of $8.0 to $8.2 billion Take-Two Interactive Software, Inc. (NASDAQ:TTWO) today reported results for the fourth quarter of its fiscal year 2026, ended March 31, 2026. For further information, please see the fourth quarter fiscal 2026 results slide deck posted to the Company's investor relations website at take2games.com/ir. CEO Comments Strauss Zelnick, Chairman and CEO of Take-Two Interactive, stated: "Our Fiscal 2026 performance was exceptional and exceeded our initial expectations at every label. We be

    5/21/26 4:05:00 PM ET
    $TTWO
    Services-Misc. Amusement & Recreation
    Consumer Discretionary

    $NDAQ
    $PFE
    $SGEN
    $TTWO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Nasdaq Inc.

    SC 13G/A - NASDAQ, INC. (0001120193) (Subject)

    11/12/24 3:53:01 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G filed by Nasdaq Inc.

    SC 13G - NASDAQ, INC. (0001120193) (Subject)

    11/8/24 10:52:39 AM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance

    Amendment: SEC Form SC 13G/A filed by Nasdaq Inc.

    SC 13G/A - NASDAQ, INC. (0001120193) (Subject)

    11/4/24 1:18:47 PM ET
    $NDAQ
    Investment Bankers/Brokers/Service
    Finance